ArticleIrish journal of medical science2026
Chest wall tumors: optimizing survival through prognostic factors and reconstruction.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary malignant chest wall tumors, originating from the bones, are infrequent neoplasms. Given its heterogeneity, further research is needed to understand the implications of recurrence and related factors in patients undergoing chest wall resection.
aimsWe analyzed the association between the clinicopathological characteristics of these patients and their overall-survival (OS) and disease-free-survival (DFS).
methodsIn this study, we conducted a retrospective analysis on patients who underwent chest wall resection for primary malignant bony chest wall tumors between 2000-2023.
resultsFifty-one patients were included. The presence of Ewing tumor, prior adjuvant therapy, postoperative complications, and reduced surgical margin were significantly associated with DFS and OS in both survival and univariate analyses. The optimal surgical margin threshold was identified as greater than 3 cm. Multivariate analysis revealed that only histopathological diagnosis of Ewing tumor and an insufficient margin remained significant for worse DFS and OS (p = 0.041 and 0.024, respectively). The 5-year overall survival (OS) and disease-free survival (DFS) rates were 53.6% and 50.8%, respectively.
conclusionEnsuring effective surgery of chest wall tumors necessitates a surgical margin greater than 3 cm. Furthermore, the histopathologic classification of Ewing carcinoma emerges as another determinant impacting DFS and OS.
Indexed as
Identifiers
41499001What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.